24.29USD+2.06%Mkt Cap: 44.01M USDP/E: —Last update: 2026-05-26
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap44.01M USD
Enterprise Value47.45M USD
Revenue (TTM)24.05M USD
Gross Profit10.71M USD
Net Income (TTM)-363.00K USD
Revenue/Share14.98 USD
Last Price24.29 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees61
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS74019L5030
Valuation
P/E (Trailing)—
P/E (Forward)62.97
PEG—
EV/EBITDA205.41
EV/Revenue1.97
P/S1.83
P/B3.00
EPS (TTM)-0.45
EPS (Forward)0.39
52W Range
9.00062% of range33.63
52W High33.63 USD
52W Low9.000 USD
Profitability
Gross Margin44.52%
Oper. Margin8.09%
EBITDA Margin0.96%
Profit Margin-1.51%
ROE-2.49%
ROA-1.70%
Growth
Revenue Growth22.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF685.00K USD
CapEx (TTM)326.00K USD
FCF Margin0.87%
FCF Yield0.48%
Net Debt1.00M USD
Net Debt/EBITDA4.34
Balance Sheet
Debt/Equity0.25
Current Ratio1.61
Quick Ratio1.24
Book Value/Sh8.176 USD
Cash/Share1.486 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateApr 29, 2019
Splits
Last Split1:20
Split DateSep 22, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.79M
Float1.42M
Insiders11.94%
Institutions18.01%
Short Interest
Short Ratio0.2d
Short % Float0.44%
Short % Out.0.40%
Shares Short7.08K
Short (prev mo.)6.07K
Technical
SMA 5027.84 (-12.7%)
SMA 20022.81 (+6.5%)
Beta1.38
S&P 52W Chg28.31%
Avg Vol (30d)34.81K
Avg Vol (10d)34.99K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—